SANTUCCI, MARIA ALESSANDRA
Dettaglio
SANTUCCI, MARIA ALESSANDRA
DIPARTIMENTO DI MEDICINA SPECIALISTICA, DIAGNOSTICA E SPERIMENTALE
Pubblicazioni
Risultati 1 - 20 di 53 (tempo di esecuzione: 0.001 secondi).
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File | |
---|---|---|---|---|---|---|---|
1 | 14-3-3 Binding and Sumoylation Concur to the Down-Modulation of β-catenin Antagonist chibby 1 in Chronic Myeloid Leukemia | Mancini, Manuela; Leo, Elisa; Takemaru, Ken-Ichi; Campi, Virginia; Castagnetti, Fausto; Soverini,... Simona; De Benedittis, Caterina; Rosti, Gianantonio; Cavo, Michele; Santucci, Maria Alessandra; Martinelli, Giovanni | 2015 | PLOS ONE | 1.01 Articolo in rivista | ||
2 | 14-3-3 ligand prevents nuclear import of c-ABL protein in chronic myeloid leukemia | Mancini M; Veljkovic N; Corradi V; Zuffa E; Corrado P; Pagnotta E; Martinelli G; Barbieri E; Sant...ucci MA. | 2009 | TRAFFIC | 1.01 Articolo in rivista | - | |
3 | 9-HSA INDUCES APOPTOSIS AND INCREASES SENSITIVITY TO IMATINIB IN IMATINIB RESISTANT COLON CANCER CELLS | Pagnotta E.; Calonghi N.; Parolin C.; Mangano C.; Boga C.; Naldi M.; Santucci M.A.; Masotti L. | 2006 | ITALIAN JOURNAL OF BIOCHEMISTRY | 4.02 Riassunto (Abstract) | - | |
4 | 9-HSA INDUCES APOPTOSIS AND INCREASES SENSITIVITY TO IMATINIB IN IMATINIB RESISTANT COLON CANCER CELLS | Pagnotta E.; Calonghi N.; Parolin C.; Mangano C.; Nuccitelli A.; Boga C.; Santucci M.A.; Masotti L. | 2006 | fondazione per le biotecnologie | 4.02 Riassunto (Abstract) | - | |
5 | 9-Hydroxystearic acid upregulates p21WAF1 in HT29 cancer cells. | N. CALONGHI; C. CAPPADONE; E. PAGNOTTA; G. FARRUGGIA; F. BUONTEMPO; C. BOGA; G.L. BRUSA; M.A. SAN...TUCCI; MASOTTI L. | 2004 | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | 1.01 Articolo in rivista | - | |
6 | A new class of dual SRC/ABL kinase inhibitors for the treatment of imatinib-resistant chronic myeloid leukemias | Corradi V.; Mancini M.; Corrado P.; Barbieri E.; Santucci M.A.; Schenone S.; Botta M. | 2007 | s.n | 4.02 Riassunto (Abstract) | - | |
7 | Acetylation of FOXO3a transcription factor in response to imatinib of chronic myeloid leukemia | Corrado P; Mancini M; Brusa G; Petta S; Martinelli G; Barbieri E; Santucci MA | 2009 | LEUKEMIA | 1.01 Articolo in rivista | - | |
8 | Apoptotic death of Bcr-Abl-expressing myeloid progenitors in response to the m-Tor inhibitor RAD001 (Everolimus) is promoted by the nuclear import of c-Abl | Mancini M.; Zuffa E.; Corrado P.; Brusa G.; Petta S.; Pagnotta E.; Santucci M.A. | 2006 | s.n | 4.02 Riassunto (Abstract) | - | |
9 | BCR-ABL1-associated reduction of beta catenin antagonist Chibby1 in chronic myeloid leukemia. | Leo E;Mancini M;Aluigi M;Luatti S;Castagnetti F;Testoni N;Soverini S;Santucci MA;Martinelli G | 2013 | PLOS ONE | 1.01 Articolo in rivista | ||
10 | C6-Unsubstituted Pyrazolo[3,4-d]pyrimidines Are Dual Src/Abl Inhibitors Effective against Imatinib Mesylate Resistant Chronic Myeloid Leukemia Cell Lines. | Santucci MA; Corradi V; Mancini M; Manetti F; Radi M; Schenone S; Botta M. | 2009 | CHEMMEDCHEM | 1.01 Articolo in rivista | - | |
11 | A calpain-cleaved fragment of β-catenin promotes BCRABL1+ cell survival evoked by autophagy induction in response to imatinib | Manuela Mancini;Elisa Leo;Virginia Campi;Fausto Castagnetti;Luca Zazzeroni;Gabriele Gugliotta;Mar...ia Alessandra Santucci;Giovanni Martinelli | 2014 | CELLULAR SIGNALLING | 1.01 Articolo in rivista | - | |
12 | Chibby 1: A new component of β-catenin-signaling in chronic myeloid leukemia | Mancini, Manuela; Soverini, Simona; Gugliotta, Gabriele; Santucci, MARIA ALESSANDRA; Rosti, Giana...ntonio; Cavo, Michele; Martinelli, Giovanni; Castagnetti, Fausto | 2017 | ONCOTARGET | 1.01 Articolo in rivista | - | |
13 | Chibby drives β catenin cytoplasmic accumulation leading to activation of the unfolded protein response in BCR-ABL1+ cells | Manuela Mancini;Elisa Leo;Ken-Ichi Takemaru;Virginia Campi;Enrica Borsi;Fausto Castagnetti;Gabrie...le Gugliotta;Maria Alessandra Santucci;Giovanni Martinelli | 2013 | CELLULAR SIGNALLING | 1.01 Articolo in rivista | - | |
14 | CHK2 drives late G1/early S phase arrest of clonal myeloid progenitors expressing the p210 BCR-ABL tyrosine kinase in response to STI571 | MAZZACURATI L; PATTACINI L; BRUSA G; MANCINI M; BENVENUTI M; BARBIERI E; MARTINELLI G.; BACCARANI... M; GREENBERGER JS; SANTUCCI MA | 2004 | HEMATOLOGY JOURNAL | 1.01 Articolo in rivista | - | |
15 | COVALENT MODIFICATIONS OF HISTONE H4 NH2-TERMINAL TAILS ASSOCIATED WITH P210 BCR-ABL TYROSINE KINASE | Brusa G.; Parisi D.; Calonghi N.; Calabrò A.; Mancini M.; Zuffa E.; Arcangeli E.; Santucci M.A. | 2004 | Mario Cazzola | 4.01 Contributo in Atti di convegno | - | |
16 | Cyclin-dependent kinase 2 (Cdk2) activity at the G1 to S boundary has a role in the resistance of Chronic Myeloid Leukemia (CML) haematopoietic progenitors to the tyrosine kinase inhibitor STI571 (Imatinib) | M. Mancini; G. Brusa; A. Calabrò; N. Calonghi; E. Pagnotta; M. Alessandra Santucci; L. Masotti | 2004 | Graphital | 4.01 Contributo in Atti di convegno | - | |
17 | Cytoplasmatic compartmentalization by Bcr-Abl promotes TET2 loss-of-function in chronic myeloid leukemia | Manuela Mancini;Nevena Veljkovic;Elisa Leo;Michela Aluigi;Enrica Borsi;Chiara Galloni;Ilaria Iaco...bucci;Enza Barbieri;Maria Alessandra Santucci | 2012 | JOURNAL OF CELLULAR BIOCHEMISTRY | 1.01 Articolo in rivista | - | |
18 | Discovery and SAR of 1,3,4-thiadiazole derivatives as potent Abl tyrosine kinase inhibitors and cytodifferentiating agents. | Radi M; Crespan E; Botta G; Falchi F; Maga G; Manetti F; Corradi V; Mancini M; Santucci MA; Schen...one S; Botta M. | 2008 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1.01 Articolo in rivista | - | |
19 | DNA methyltransferase 1 drives transcriptional down-modulation of β catenin antagonist Chibby1 associated with the BCR-ABL1 gene of chronic myeloid leukemia. | Leo, E; Mancini, M; Castagnetti, F; Gugliotta, G; Santucci, Ma; Martinelli, G. | 2015 | JOURNAL OF CELLULAR BIOCHEMISTRY | 1.01 Articolo in rivista | - | |
20 | Endoplasmic reticulum stress initiates apoptotic death induced by STI571 inhibition of p210 bcr-abl tyrosine kinase. | PATTACINI L; MANCINI M; MAZZACURATI L; BRUSA G; BENVENUTI M; MARTINELLI G.; BACCARANI M; SANTUCCI... MA. | 2004 | LEUKEMIA RESEARCH | 1.01 Articolo in rivista | - |